Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: Relationship with erythropoietin requirements
- 1 September 2001
- journal article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 38 (3), 510-517
- https://doi.org/10.1053/ajkd.2001.26839
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Is Plasma Ac-SDKP Level a Reliable Marker of Chronic Angiotensin-Converting Enzyme Inhibition in Hypertensive Patients?Hypertension, 1998
- High Plasma Level of N -Acetyl-Seryl-Aspartyl-Lysyl-ProlineHypertension, 1997
- Erythropoietin in chronic renal failureKidney International, 1996
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaThe New England Journal of Medicine, 1993
- Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassayBiochemical and Biophysical Research Communications, 1990
- Do polyamines play a role in the pathogenesis of the anemia of end-stage renal disease?Kidney International, 1989
- Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failureKidney International, 1984
- Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis PatientsAmerican Journal of Nephrology, 1984
- ENALAPRIL (MK-421) AND THE WHITE CELL COUNT AND HAEMATOCRITThe Lancet, 1982
- Effect of parathyroid hormone on erythropoiesis.JCI Insight, 1981